Wed.Feb 28, 2024

article thumbnail

Smoking Cannabis Linked With Higher Risk of Cardiovascular Disease

Drug Topics

Analysis of participants who never used tobacco cigarettes showed that daily cannabis use was associated a higher risk of both heart attack and stroke.

200
200
article thumbnail

Local Pharmacies On the Brink, New Survey Reveals

Pharmacy Times

Congress and the administration still have time (NOT MUCH) to act

149
149
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Respiratory Disease Trifecta: What to Know About COVID-19, Flu, and RSV

Drug Topics

In order to provide the best care, it’s crucial that pharmacists stay up-to-date on the latest guidance and data for flu, COVID-19, and RSV—even when that information is constantly changing.

200
200
article thumbnail

Navigating the Changing Tides of PBM Audits: A Forecast and Strategy for Independent Pharmacies

Pharmacy Times

By understanding the nuances of PBM audit strategies, pharmacies can implement proactive measures to mitigate risks of recoupment, payment suspensions, and, in severe cases, network termination.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

‘Brain fog’ is one of Covid-19’s most daunting symptoms. A new study measures its impact

STAT

Of all the lingering symptoms of long Covid , difficulty focusing and thinking, known as brain fog , may be the most frightening and baffling. A new study published Wednesday in the New England Journal of Medicine, which looks at how much cognition is impaired in the months after a coronavirus infection, shows that Covid-19’s impact can be measured in the equivalent of IQ points.

Hospitals 145
article thumbnail

Pharmacists Are Key Access Point for Patients Amid Alabama Ruling on IVF

Pharmacy Times

In LePage v. Center for Reproductive Medicine, the Alabama Supreme Court ruled that “extrauterine embryos” are considered children, causing some infertility clinics to halt IVF processes.

139
139

More Trending

article thumbnail

ViVE 2024: Health systems are making big bets on AI. Here's how

Fierce Healthcare

LOS ANGELES — AI took center stage at the ViVE 2024 conference this week and health systems across the country are deploying the tech to tackle issues from easing the drudgery of medical docum | AI took center stage at the ViVE 2024 conference this week and health systems across the country are deploying the tech to tackle issues from easing the drudgery of medical documentation to making it easier for patients to get information about their medical care.

article thumbnail

STAT+: White House to hold a listening session on reforming pharmacy benefit managers

STAT

In a bid to combat prescription drug costs, the White House will hold a listening session on Monday in search of ways to reform pharmacy benefit managers , according to people familiar with the plans. The list of attendees includes representatives from the federal government and industry, who are expected to provide insights into how the largest pharmacy benefit managers determine which medicines are covered by insurers and employers, as well as prices that are paid at pharmacy counters.

Insurance 145
article thumbnail

Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals

Pharmacy Times

The podcast highlights addressing misinformation, the impact of celebrity endorsements in pharmaceuticals, and the important role of pharmacists in educating patients.

131
131
article thumbnail

Q&A: The scientific integrity sleuth taking on the widespread problem of research misconduct

STAT

Elisabeth Bik, a microbiologist by training, has become one of the world’s most influential science detectives. An authority on scientific image analysis who’s been profiled in The New Yorker for her unique ability to spot duplicated or doctored photographs, she appeared frequently in the news over the past year as one of the experts who raised research misconduct concerns that led to an investigation into, and the eventual departure of, former Stanford president Marc Tessier-Lavig

144
144
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Experts, government outline healthcare strategies for gun violence prevention at Northwell's annual forum

Fierce Healthcare

Providers, researchers and government officials gathered Tuesday to discuss the "urgent public health crisis" of gun violence and throw their weight behind a new multimillion-dollar aware | The event, which emphasized the role of healthcare professionals in addressing gun violence, came with the announcement of an industry-backed, multimillion-dollar awareness and prevention campaign.

128
128
article thumbnail

Why won’t Medicare deliver food to sick seniors, if it could get them healthy?

STAT

WASHINGTON – Some twelve percent of traditional Medicare beneficiaries have heart failure. Roughly a quarter have diabetes. There’s early evidence suggesting that both conditions — and a slew of others — could be better managed with pre-made healthy meals. So why doesn’t Medicare try out delivering food to sick seniors?

144
144
article thumbnail

Northwell Health, Nuvance Health unveil 28-hospital merger deal

Fierce Healthcare

Danbury, Connecticut-based Nuvance Health is joining Northwell Health, New York’s largest provider and private employer, under a strategic merger agreement unveiled Wednesday. | The $18 billion combination, which still requires regulatory signoffs, would give Northwell a foothold in Connecticut and promises "significant investments" for Nuvance.

Hospitals 124
article thumbnail

STAT+: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry. It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic.

Insurance 143
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Seeking blockbuster status, UCB eyes four new indications for psoriasis med Bimzelx in 2024

Fierce Pharma

After a busy 2023 marked by multiple drug approvals, UCB isn’t resting on its laurels. | After an initial FDA approval came later than anticipated, UCB is looking to quickly grow Bimzelx. The company is eying four new indications and potential peak sales of 4 billion euros.

FDA 122
article thumbnail

Meet the contenders for the STAT Madness 2024 crown. Voting begins March 1

STAT

The 64 contestants whose discoveries and innovations have been selected for the 2024 edition of STAT Madness come from 50 institutions across the U.S. The teams include a Nobel laureate (Jennifer Doudna) and biotech big shots (Robert Langer and David Liu), but also up-and-comers. STAT Madness is our annual bracket-style competition in which readers vote on the most important and impactful biomedical and health research published in the past year by scientists at universities and independent labs

142
142
article thumbnail

Beacon Therapeutics unveils promising interim results for gene therapy AGTC-501

Pharmaceutical Technology

AGTC-501 is in Phase II development for retinitis in the SKYLINE trial (NCT03316560) and addresses unmet needs within the retinitis space

122
122
article thumbnail

Amid measles outbreaks, U.K. launches vaccination ad campaign to boost childhood immunizations

STAT

LONDON — Facing a growing outbreak of measles, the U.K. has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. The campaign, starting March 4, features children talking about their lack of protection from infections like measles and whooping cough if they’re not vaccinated.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

'Podnosis': Maternal mental health in the spotlight

Fierce Healthcare

This week on “Podnosis,” we explore the critical issue of maternal mental health. | This week on "Podnosis," Editor-in-Chief Ayla Ellison explores the critical issue of maternal mental health in an interview with Dr. Ken Levey, co-founder and CEO of Mother Goose Health.

122
122
article thumbnail

Chikungunya vaccine approved for select groups by CDC advisory panel

STAT

In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH. It will become U.S. vaccination policy when Mandy Cohen, director of the Centers for Disease Control and Prevention, signs off on the recommendation from th

Vaccines 126
article thumbnail

Walgreens to accept Medicare Advantage OTC benefits online

Fierce Healthcare

Walgreens will now accept a slew of Medicare Advantage supplemental benefits online, including the option for home delivery, the company announced this week. | Walgreens will now accept a slew of Medicare Advantage supplemental benefits online, including the option for home delivery, the company announced this week.

119
119
article thumbnail

STAT+: Pharmalittle: We’re reading about the FTC vs. PBMs, FDA adcomm voting and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

FDA 125
article thumbnail

Rare Disease Day: Enhancing clinical trial success in rare diseases

pharmaphorum

Rare Disease Day is an opportunity to highlight the importance of enhancing clinical trial success in rare diseases for the benefit of patients.

119
119
article thumbnail

Biden ‘continues to be fit for duty,’ his doctor says, after president undergoes annual physical

STAT

BETHESDA, Md. — President Joe Biden  “continues to be fit for duty,” his doctor wrote Wednesday after conducting an annual physical that is being closely watched as the 81-year-old  seeks reelection  in November. Dr. Kevin O’Connor, Biden’s physician, wrote that the president is adjusting well to a new device that helps control his sleep apnea and has experienced some hip discomfort but also works out five times per week.

122
122
article thumbnail

After steep cost cuts, Novavax's fourth-quarter performance falls short of expectations

Fierce Pharma

As Novavax emerges from its “transition year” in 2023, the vaccine maker is still raising concerns among Wall Street investors in early 2024. | As Novavax emerges from its “transition year” in 2023, the vaccine maker is still raising concerns among Wall Street investors in early 2024.

Vaccines 119
article thumbnail

Power of digital technology and partnership to accelerate delivery of new medicines to patients

pharmaphorum

Discover how digital technology and strategic partnerships are revolutionising the pharmaceutical industry, enabling faster delivery of life-saving medicines to patients, while advancing humanity's fight against diseases.

116
116
article thumbnail

How did store brands fare in 2023?

Drug Store News

Sales of store brands increased $10.1 billion to a record $236.3 billion last year compared to 2022, per PLMA's new report.

115
115
article thumbnail

AbbVie inks $713m deal for OSE chronic inflammation drug

pharmaphorum

AbbVie has made another bolt-on deal in the immunology and inflammation category, paying $48 million upfront for rights to an antibody in preclinical development at OSE Immunotherapeutics. There’s another $665 million in potential milestones and a royalty tied to the deal, which focuses on OSE-230, billed as a potentially first-in-class activator of ChemR23, a G-protein coupled receptor (GPCR) found on some white blood cells.

115
115
article thumbnail

HRG reviews 1,634 new HBW items in 2023

Drug Store News

In 2023, HRG awarded 148 products predicted to have the highest potential for future success and drive profitability in independent pharmacies and other channels.

article thumbnail

Viatris splashes out $350m on pair of Idorsia therapies

pharmaphorum

Viatris licenses two late-stage drugs from Idorsia for heart attack and lupus, both claimed to have blockbuster sales potential, for $350m upfront.

115
115
article thumbnail

Dollar General now accepting supplemental benefits chainwide

Drug Store News

Dollar General customers can now purchase food, produce, OTCs and additional wellness products in more than 20,000 stores across the country using health supplemental benefits.

115
115
article thumbnail

After Idorsia deal, Viatris' dealmaking appetite remains strong, CEO says

Fierce Pharma

On the back of its $350 million deal for two late-stage Idorsia assets, Viatris will continue to be “opportunistic” when it comes to making future business development grabs—especially on the comme | On the back of its $350 million deal for two late-stage Idorsia assets, Viatris will continue to be “opportunistic” when it comes to making future business development grabs—especially on the commercial side—executives said Wednesday.

115
115
article thumbnail

Understanding the Foundations of Pharmacy Financial Health

Drug Topics

Pharmacy schools specialize in training students as experts in patient care—not as expert business owners.